Comparisons

AI Answers About Athlete's Foot: Model Comparison

By Editorial Team — reviewed for accuracy Updated
Last reviewed:

Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Athlete’s Foot: Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.

Athlete’s foot, or tinea pedis, is the most common fungal skin infection, affecting an estimated ~15 to 25 percent of the population at any given time. In the United States, ~approximately 70 percent of people will develop athlete’s foot at some point in their lives. The condition is more common in men than women, in adults over adolescents, and in people who use communal showers, pools, and locker rooms. ~approximately 30 to 70 percent of people with athlete’s foot also develop toenail fungus, as the same dermatophyte organisms can spread to the nails.

We tested four AI models with a athlete’s foot scenario to evaluate their understanding and management guidance.

The Question We Asked

“I’m a 41-year-old man who works out at the gym regularly. I’ve had itchy, peeling skin between my toes for about a month, and now it has spread to the soles of my feet with small blisters. I tried an over-the-counter antifungal cream for a week, but it hasn’t helped much. What is athlete’s foot, why isn’t the cream working, and how do I get rid of it for good?”

Model Responses: Summary Comparison

CriteriaGPT-4Claude 3.5GeminiMed-PaLM 2
Explained dermatophyte infectionYesYesPartialYes
Discussed clinical typesYesYesNoYes
Addressed treatment durationYesYesYesYes
Covered prevention strategiesYesYesYesPartial
Discussed oral antifungalsYesYesNoYes
Explained treatment failure reasonsYesYesPartialYes
Mentioned toenail fungus riskYesYesNoYes
Addressed shoe and sock hygieneYesYesYesPartial

What Each Model Got Right

GPT-4

GPT-4 provided a thorough explanation of athlete’s foot as a dermatophyte infection, identifying the common causative organisms including Trichophyton rubrum and Trichophyton mentagrophytes. The model correctly identified the three clinical presentations: interdigital, moccasin type, and vesicular or inflammatory, explaining that the patient’s presentation with both interdigital and vesicular components suggests a moderately aggressive infection. GPT-4 explained that one week of antifungal treatment is insufficient, as most topical antifungals require four to six weeks of consistent application to fully eradicate the fungus. The model discussed when to escalate to oral antifungals.

Claude 3.5

Claude 3.5 delivered the most practical and actionable response. The model addressed the patient’s frustration with treatment failure by explaining the most common reasons antifungal creams fail: insufficient treatment duration, inadequate application technique, continued exposure to the causative environment, and use of an antifungal that does not cover the specific organism. Claude 3.5 provided a detailed treatment plan including specific antifungal recommendations, proper application technique covering all affected areas plus a margin of surrounding skin, and the importance of continuing treatment for at least one week after symptoms resolve. The model also provided comprehensive prevention strategies including foot hygiene, footwear management, and gym-specific precautions.

Gemini

Gemini provided a straightforward guide to managing athlete’s foot with emphasis on practical prevention strategies. The model discussed the importance of keeping feet dry, wearing moisture-wicking socks, alternating shoes, and using shower sandals in communal areas. Gemini correctly noted the importance of completing the full course of antifungal treatment rather than stopping when symptoms improve.

Med-PaLM 2

Med-PaLM 2 offered the most scientifically detailed response, discussing the pathophysiology of dermatophyte infections and the factors that promote fungal colonization including warmth, moisture, and skin maceration. The model discussed the mechanism of action of different antifungal classes including azoles, allylamines, and ciclopirox. Med-PaLM 2 covered oral antifungal options including terbinafine and itraconazole for resistant or extensive infections, discussing their efficacy, drug interactions, and monitoring requirements.

What Each Model Got Wrong or Missed

GPT-4

GPT-4 did not provide sufficient practical detail on daily foot care and prevention strategies to prevent recurrence. While the model covered the medical aspects well, a patient dealing with a chronic or recurrent condition needs specific actionable guidance for their daily routine. The model also did not address the social embarrassment associated with athlete’s foot.

Claude 3.5

Claude 3.5 did not discuss the different clinical types of athlete’s foot in sufficient detail, which helps patients understand why their presentation may require different treatment approaches. The model could also have provided more information about when to suspect an alternative diagnosis such as eczema, contact dermatitis, or psoriasis, which can mimic athlete’s foot.

Gemini

Gemini did not discuss oral antifungal options, which are important for patients with extensive or treatment-resistant infections. The model also did not mention the risk of athlete’s foot spreading to the toenails, which is a significant concern for long-term management. The discussion of different athlete’s foot types was absent, potentially leading to inadequate treatment approach.

Med-PaLM 2

Med-PaLM 2 was overly focused on pharmacology and fungal biology at the expense of practical daily management advice. The model did not adequately address prevention strategies, footwear hygiene, or the environmental factors that contribute to recurrence. Most patients with athlete’s foot need practical lifestyle guidance rather than detailed antifungal pharmacology.

Red Flags All Models Should Mention

All AI models should flag these concerns in the context of athlete’s foot:

  • Infection spreading to the toenails or other body areas including the groin
  • Signs of secondary bacterial infection including increased redness, warmth, spreading swelling, or pus
  • Fungal infection in a person with diabetes or a compromised immune system
  • Failure to improve after four to six weeks of appropriate antifungal treatment
  • Vesicular or bullous eruptions suggesting a more aggressive inflammatory infection
  • Cellulitis developing around the affected area with red streaks or fever

When to Trust AI vs. See a Doctor

When AI Information May Be Helpful

AI tools can help patients understand the causes of athlete’s foot and the importance of proper treatment duration, which is the most common reason for treatment failure. AI can provide practical prevention strategies and help patients understand the difference between types of antifungal products. AI can also help patients determine when their condition warrants a medical visit for prescription-strength treatment.

When You Must See a Doctor

Medical evaluation is warranted if athlete’s foot does not respond to four to six weeks of appropriate over-the-counter antifungal treatment. A healthcare provider can confirm the diagnosis, which may include microscopic examination or culture, and prescribe oral antifungals if needed. Patients with diabetes or immunosuppression should seek earlier evaluation due to increased risk of complications including secondary bacterial infection.

For more on AI’s role in health guidance, visit our medical AI accuracy page.

Methodology

We submitted the identical patient scenario to GPT-4, Claude 3.5 Sonnet, Gemini 1.5 Pro, and Med-PaLM 2 in March 2026. Each model received the prompt without prior conversation context. Responses were evaluated by a dermatologist and an infectious disease specialist against current AAD guidelines for tinea pedis management. Models were scored on medical accuracy, treatment comprehensiveness, practical guidance, and patient communication quality.

Key Takeaways

  • All four models correctly explained athlete’s foot as a fungal infection and addressed the patient’s concern about treatment failure, with most identifying insufficient treatment duration as the likely cause.
  • Claude 3.5 provided the most practical and comprehensive management plan, addressing treatment, prevention, and the specific causes of antifungal treatment failure.
  • Oral antifungal options for resistant cases were discussed by GPT-4, Claude 3.5, and Med-PaLM 2 but entirely omitted by Gemini.
  • Prevention strategies are critical for a condition with high recurrence rates and were best addressed by Claude 3.5 and Gemini.
  • Athlete’s foot is usually manageable with proper treatment but may require medical evaluation if it persists, and AI should help patients optimize their self-care while knowing when to seek professional help.

Next Steps

If you found this comparison helpful, explore these related resources:


DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.